ACCESSWIRE
26 Jan 2023, 17:05 GMT+10
GOTHENBURG, SWEDEN / ACCESSWIRE / January 26, 2023 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV)
Fourth quarter 2022 (October 1 - December 31)
Significant events during the quarter
Events after the end of the period
The period 2022 (January 1 - December 31)
Significant events in the reporting period
CEO comment
'2022 was a strong year for XVIVO. Sales amounted to SEK 415 million (258) with organic growth of 30 percent in local currencies. The final fourth quarter testifies to a continued recovery of transplant activity worldwide and strong momentum for machine perfusion in particular. XVIVO's sales during the quarter set new records and totaled SEK 132 million (86). All of the business areas delivered strong growth, both year-on-year and sequentially. In summing up 2022, it is clear that XVIVO has achieved several significant milestones during the year toward our goal of becoming the leading transplantation company for all major organs. The strong finish to 2022 means we have the wind in our sails and self-confidence, and we are determined to make 2023 yet another successful year for XVIVO' - Christofer Rosenblad, CEO.
For further information, please contact:
Christoffer Rosenblad, CEO, +46 73 519 21 59, e-mail: christoffer.rosenblad@xvivogroup.com
Kristoffer Nordström, CFO, +46 73 519 21 64, e-mail: kristoffer.nordstrom@xvivogroup.com
Conference Call
Christoffer Rosenblad, CEO and Kristoffer Nordström, CFO, will present the report in a conference call today at 2 PM CET. For registration to the conference call, see information in previous press release: https://www.xvivoperfusion.com/mfn_news/xvivo-presents-report-on-operations-2022
About Us
Founded in 1998, XVIVO is the only medical technology company dedicated to extending the life of all major organs - so transplant teams around the world can save more lives. Our solutions allow leading clinicians and researchers to push the boundaries of transplantation medicine. XVIVO is headquartered in Gothenburg, Sweden, and has offices and research sites on two continents. The company is listed on Nasdaq and has the ticker symbol XVIVO. More information can be found on the website www.xvivogroup.com.
This information is information that XVIVO Perfusion AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2023-01-26 07:30 CET.
Attachments
XVIVO Report On Operations 2022
SOURCE: XVIVO Perfusion AB
Get a daily dose of St Louis Star news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to St Louis Star.
More InformationCHEYENNE, Wyoming: A Wyoming bill outlawing the use or prescription of medication abortion pills, which was passed by the state's ...
DENVER, Colorado: The Southern Nevada Water Authority has voted to accept a $2.4 million grant from the US Bureau of ...
WASHINGTON D.C.: The US government has reported that the exceptionally wet winter in California this year will offer relief from ...
FRANKFURT, GERMANY: Authorities said that as part of a crackdown on gangs suspected of blowing up ATM machines and stealing ...
BERLIN, Germany: Germany will send a cabinet minister to visit Taiwan next week, at a time when Berlin is reviewing ...
ZURICH, Switzerland - Depositors will be fully protected, shareholders will have their equity dwarfed, while bond holders will be largely ...
NEW YORK, New York - Wall Street continued its advance on Tuesday as investors continued to weigh up the health ...
WASHINGTON D.C.: The US State Department has issued a travel warning regarding dangerous fake pills sold at pharmacies in Mexico, ...
FRANKFURT, Germany: The German Automobilwoche magazine has reported that as part of its efforts to switch to selling electric vehicles ...
NEW YORK, New York - U.S. stocks rallied on Monday following the weekend buy-in of Credit Suisse by UBS, which ...
WASHINGTON D.C.: The US Federal Reserve Bank has announced that cash-strapped banks throughout the US borrowed some $300 billion during ...
BEIJING, China: Following the inability of China Huarong Asset Management Co Ltd to release financial reporting obligations in 2020, China ...